BSE Live
Jan 02, 16:01Prev. Close
3847.75
Open Price
3844.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 02, 15:51Prev. Close
3848.40
Open Price
3856.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 169.23 | 169.23 | 169.23 | 84.62 | 84.62 | |
| Total Share Capital | 169.23 | 169.23 | 169.23 | 84.62 | 84.62 | |
| Reserves and Surplus | 7,421.46 | 6,686.92 | 6,028.84 | 5,868.33 | 5,752.55 | |
| Total Reserves and Surplus | 7,421.46 | 6,686.92 | 6,028.84 | 5,868.33 | 5,752.55 | |
| Total Shareholders Funds | 7,590.69 | 6,856.15 | 6,198.07 | 5,952.95 | 5,837.17 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1,191.75 | 1,603.78 | 2,496.22 | 2,123.22 | 2,941.07 | |
| Deferred Tax Liabilities [Net] | 828.72 | 656.05 | 401.94 | 193.56 | 0.00 | |
| Other Long Term Liabilities | 160.12 | 74.66 | 75.26 | 46.28 | 35.17 | |
| Long Term Provisions | 501.27 | 444.69 | 393.06 | 368.74 | 369.62 | |
| Total Non-Current Liabilities | 2,681.86 | 2,779.18 | 3,366.48 | 2,731.80 | 3,345.86 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 1,834.34 | 2,333.64 | 2,801.08 | 1,894.88 | 1,884.39 | |
| Trade Payables | 1,820.02 | 2,089.32 | 1,678.80 | 1,674.44 | 2,066.81 | |
| Other Current Liabilities | 654.70 | 602.15 | 573.71 | 434.74 | 509.36 | |
| Short Term Provisions | 408.13 | 400.14 | 393.71 | 411.03 | 431.06 | |
| Total Current Liabilities | 4,717.19 | 5,425.25 | 5,447.30 | 4,415.09 | 4,891.62 | |
| Total Capital And Liabilities | 14,989.74 | 15,060.58 | 15,011.85 | 13,099.84 | 14,074.65 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 3,455.65 | 3,296.97 | 2,771.60 | 2,702.59 | 2,883.34 | |
| Intangible Assets | 4,152.37 | 4,503.11 | 5,012.35 | 3,460.58 | 3,840.06 | |
| Capital Work-In-Progress | 367.26 | 280.80 | 688.24 | 544.34 | 745.41 | |
| Fixed Assets | 8,086.16 | 8,160.59 | 8,549.35 | 6,792.99 | 7,612.78 | |
| Non-Current Investments | 43.57 | 31.80 | 42.70 | 42.33 | 42.09 | |
| Deferred Tax Assets [Net] | 594.15 | 555.13 | 543.67 | 493.65 | 421.66 | |
| Long Term Loans And Advances | 3.37 | 2.51 | 2.50 | 1.75 | 2.02 | |
| Other Non-Current Assets | 301.04 | 361.04 | 206.95 | 214.99 | 131.65 | |
| Total Non-Current Assets | 9,367.17 | 9,449.10 | 9,682.67 | 7,805.19 | 8,551.43 | |
| CURRENT ASSETS | ||||||
| Current Investments | 112.21 | 141.04 | 156.09 | 183.98 | 139.05 | |
| Inventories | 2,541.25 | 2,279.07 | 2,229.64 | 2,462.32 | 2,681.20 | |
| Trade Receivables | 1,866.45 | 1,844.30 | 1,943.82 | 1,632.48 | 1,523.37 | |
| Cash And Cash Equivalents | 579.46 | 839.04 | 571.46 | 403.41 | 603.50 | |
| Short Term Loans And Advances | 4.22 | 3.05 | 1.71 | 2.61 | 3.08 | |
| OtherCurrentAssets | 518.98 | 504.98 | 426.46 | 609.85 | 573.02 | |
| Total Current Assets | 5,622.57 | 5,611.48 | 5,329.18 | 5,294.65 | 5,523.22 | |
| Total Assets | 14,989.74 | 15,060.58 | 15,011.85 | 13,099.84 | 14,074.65 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 465.58 | 575.06 | 619.01 | 505.35 | 324.34 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 162.41 | 162.41 | 162.41 | 77.80 | 77.80 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 43.57 | 31.80 | 42.70 | 42.33 | 42.09 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 112.21 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 141.04 | 156.06 | 183.98 | 139.05 |
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012